Demographic data | | | | |
No. of patients (F/M) | | 26 (22/4) | | 28 (20/8) |
Mean (SE) age in years | | 41.3 (1.5) | | 37.3 (2.0) |
Mean (SE) disease duration in years | | 10.7 (1.2) | | 10.0 (1.4) |
Mean baseline EDSS (median, range) | | 2.3 (2.0, 0 to 5.5) | | 2.7 (2.0, 0 to 6.0) |
Annual progression rate of disease (SE)† | | 0.3 (0.1) | | 0.4 (0.2) |
Study data* | | | | |
Years of follow up | | 11.4 | | 18.2 |
No. of exacerbations | | 28 | | 38 |
Median (mean) (SE) annual exacerbation rate | | 3.0 (3.3) (0.4) | | 2.6 (3.2) (0.5) |
No. of exacerbations with sustained progression‡ | | 8 | | 7 |
Median annual exacerbation rate for exacerbations with sustained progression (mean (SE)) | | 0.0 (1.2) (0.5) | | 0.0 (0.4) (0.2) |